Did you mean oic 1523 of opc 1523?
Displaying all 4 drugs
OPC-14523
OPC-14523 is an antidepressant drug developed by Otsuka America Pharmaceutical.
Investigational
Matched Name: … OPC-14523 …
Matched Description: … OPC-14523 is an antidepressant drug developed by Otsuka America Pharmaceutical. …
Matched Salts name: … OPC-14523 mesylate ... OPC-14523 hydrochloride …
Matched Description: … OPC-14523 is an antidepressant drug developed by Otsuka America Pharmaceutical. …
Matched Salts name: … OPC-14523 mesylate ... OPC-14523 hydrochloride …
OPC-51803
OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist. It is a V(2)-selective agonist that produces a significant antidiuretic action after single and multiple oral dosing in AVP-deficient and normal AVP states. It is useful therapeutic drug in the treatment of hypothalamic diabetes insipidus, nocturnal enuresis, and some kinds of...
Investigational
Matched Name: … OPC-51803 …
Matched Description: … OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist. …
Matched Description: … OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist. …
OPC-28326
At low doses, OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action at alpha-2-adrenoceptors while having minimal action on systemic blood pressure, heart rate and coronary, carotid, vertebral, renal, and mesenteric blood flows. It is the only clinical compound with this profile. It is currently being...
Investigational
Matched Name: … OPC-28326 …
Matched Description: … At low doses, OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action …
Matched Description: … At low doses, OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action …
OPC1
OPC1 is an oligodendrocyte progenitor cell therapy being investigated for the treatment of acute spinal cord injury.
Investigational
Displaying all 4 drugs